| Carlos I Alarcon, MD | |
|
699 Church St Ne, Suite 220, Marietta, GA 30060-1101 | |
| (770) 422-8505 | |
| (770) 424-7449 |
| Full Name | Carlos I Alarcon |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 699 Church St Ne, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568481539 | NPI | - | NPPES |
| 524725354A | Medicaid | GA | |
| 10066191 | Other | GA | AMERIGROUP |
| 524725354B | Medicaid | GA | |
| 356358 | Other | GA | WELLCARE |
| 7382829 | Other | GA | AETNA |
| 160380 | Other | GA | BCBS OF GA |
| 16BBDFB | Other | GA | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 54534 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Kennestone Hospital | Marietta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marietta Ob Gyn Affiliates, P.a. | 2264323187 | 7 |
News Archive
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
Medical staff at Weston General Hospital are switching to smartphone-based technology to communicate patient details as an ‘archaic' paper-based system is dropped.
AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients.
Today AIDS Healthcare Foundation (AHF), the largest global AIDS organization, blasted the news that Gilead Sciences Inc. increased the prices of several of its top selling products at the beginning of the month. The California-based drug maker increased the price of its biggest seller, HIV treatment Atripla, by 5.1%. Gilead also raised the price of HIV drugs Truvada and Emtriva by 7.9%.
› Verified 7 days ago
| Entity Name | Marietta Ob Gyn Affiliates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891710679 PECOS PAC ID: 2264323187 Enrollment ID: O20040322000858 |
News Archive
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
Medical staff at Weston General Hospital are switching to smartphone-based technology to communicate patient details as an ‘archaic' paper-based system is dropped.
AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients.
Today AIDS Healthcare Foundation (AHF), the largest global AIDS organization, blasted the news that Gilead Sciences Inc. increased the prices of several of its top selling products at the beginning of the month. The California-based drug maker increased the price of its biggest seller, HIV treatment Atripla, by 5.1%. Gilead also raised the price of HIV drugs Truvada and Emtriva by 7.9%.
› Verified 7 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
Medical staff at Weston General Hospital are switching to smartphone-based technology to communicate patient details as an ‘archaic' paper-based system is dropped.
AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients.
Today AIDS Healthcare Foundation (AHF), the largest global AIDS organization, blasted the news that Gilead Sciences Inc. increased the prices of several of its top selling products at the beginning of the month. The California-based drug maker increased the price of its biggest seller, HIV treatment Atripla, by 5.1%. Gilead also raised the price of HIV drugs Truvada and Emtriva by 7.9%.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carlos I Alarcon, MD 699 Church St Ne, Suite 220, Marietta, GA 30060-1116 Ph: (770) 422-8505 | Carlos I Alarcon, MD 699 Church St Ne, Suite 220, Marietta, GA 30060-1101 Ph: (770) 422-8505 |
News Archive
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
Medical staff at Weston General Hospital are switching to smartphone-based technology to communicate patient details as an ‘archaic' paper-based system is dropped.
AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients.
Today AIDS Healthcare Foundation (AHF), the largest global AIDS organization, blasted the news that Gilead Sciences Inc. increased the prices of several of its top selling products at the beginning of the month. The California-based drug maker increased the price of its biggest seller, HIV treatment Atripla, by 5.1%. Gilead also raised the price of HIV drugs Truvada and Emtriva by 7.9%.
› Verified 7 days ago
Dr. Anushka Magal, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4800 Olde Towne Pkwy Ste 350, Marietta, GA 30068 Phone: 770-509-8858 | |
Dr. Perry G Busbee, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 833 Campbell Hill St Nw Ste 420, Marietta, GA 30060 Phone: 470-956-3860 | |
Dr. Deborah A. Taylor, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 699 Church Street, Suite 500, Marietta, GA 30060 Phone: 770-424-7100 Fax: 770-795-1969 | |
Dr. Diane Chien Lin Goh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 574 Church St Ne, Marietta, GA 30060 Phone: 770-427-0285 | |
Kimberly A Huffman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 699 Church St Ne, Suite 300, Marietta, GA 30060 Phone: 770-422-8700 Fax: 770-425-7601 | |
Dr. Fonda D Martin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 833 Campbell Hill St Nw, Suite 400, Marietta, GA 30060 Phone: 770-528-0260 Fax: 770-528-0269 | |
Dr. Heath Ross Graham, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4800 Olde Towne Pkwy, Suite 150, Marietta, GA 30068 Phone: 770-977-1510 Fax: 770-509-8858 |